How are weight loss medications being used in primary care clinics?
The PRISM study is designed to answer that question.
We are recruiting adults taking GLP-1 medications to manage their weight, like Wegovy (semaglutide), Zepbound (tirzepatide), or Saxenda (liradlutide), to be in the PRISM Study. The PRISM Study will study the patterns of how weight loss medications are used when they are prescribed in primary care clinics.
Contact us
To learn more about the PRISM Study, please call the study team at (312) 942-1282, or email crane_lab@rush.edu.
Frequently Asked Questions
On
Interested in being part of the PRISM Study?
Study Information
Principal Investigator: Melissa Crane, PhD
Registration: ClinicalTrials.gov, NCT07288294
Funding: U.S. National Institutes of Health, R01DK141570
Active period: September 16, 2025-August 31, 2028